Consultation on potential Ebola therapies and vaccines
4-5 September 2014
Geneva, Starling Hotel
List of participants:
1. Dr Marylyn Addo, Professor of Emerging Infections, Universitätsklinikum Hamburg-Eppendorf,
German Center of Infectious Diseases Research (DZIF), Hamburg, Germany
2. Dr Clement Adebamowo, Chairman, National Health Research Ethics Committee of Nigeria,
Federal Ministry of Health, Abuja, Nigeria
3. Dr Selidji Agnandji, Franceville, Gabon
4. Dr Enrica Alteri, Head of Safety and Efficacy of Medicines, Human Medicines Development and
Evaluation Unit, European Medicines Agency, London, United Kingdom of Great Britain &
Northern Ireland
5. Dr Sylvain Baize, Biology of Viral Emerging Infections, Institut Pasteur, Paris, France
6. Dr Younoussa Ballo, Secrétaire general, Ministère de la Santé, Conakry, Guinea
7. Dr Ripley Ballou, GlaxoSmithKline Biologicals SA, Rixensart, Belgium
8. Ms Helia Baradarani, Tekmira’s Manager of Medical Countermeasure Business Development,
Vancouver, Canada
9. Dr Jarbas Barbosa, Vice Minister, Ministry of Health, Brasilia, Brazil
10. Dr Jesus Barral-Guerin, Senior Manager, Vaccine Centre, Supply Division, UNICEF, Copenhagen,
Denmark
11. Dr Daniel Bausch, Associate Professor, Department of Tropical Medicine, Tulane University School
of Public Health and Tropical Medicine, New Orleans, USA
12. Dr Sina Bavari, CIV US Army Medcom USA MRIID, USA
13. Dr Stephan Becker, Direktor, Institut für Virologie, Marburg, Germany
14. Dr Laetitia Bigger, Senior Manager, Vaccines Policy, IFPMA, Geneva, Switzerland
15. Dr Fred Binka, Vice Chanceller, University of Health and Allied Sciences, Ho, Ghana
16. Dr Francisco Blanco, Chief of Medicines & Nutrition, Supply Division, UNICEF, Copenhagen,
Denmark
17. Dr Luciana Borio, Director, Office of Counterterrorism and Emerging Threats (OCET) in the Office
of the Chief Scientist, U.S. Food and Drug Administration (FDA), Rockville, USA
